id	sid	tid	token	lemma	pos
gra-816	1	1	introduction	introduction	NOUN
gra-816	1	2	hypertension	hypertension	NOUN
gra-816	1	3	is	be	AUX
gra-816	1	4	a	a	DET
gra-816	1	5	disorder	disorder	NOUN
gra-816	1	6	of	of	ADP
gra-816	1	7	circulatory	circulatory	ADJ
gra-816	1	8	regulation.sustained	regulation.sustaine	VERB
gra-816	1	9	hypertension	hypertension	NOUN
gra-816	1	10	causes	cause	NOUN
gra-816	1	11	accelerated	accelerate	VERB
gra-816	1	12	atherosclerosis	atherosclerosis	NOUN
gra-816	1	13	with	with	ADP
gra-816	1	14	coronary	coronary	ADJ
gra-816	1	15	artery	artery	NOUN
gra-816	1	16	disease	disease	NOUN
gra-816	1	17	,	,	PUNCT
gra-816	1	18	heart	heart	NOUN
gra-816	1	19	failure	failure	NOUN
gra-816	1	20	,	,	PUNCT
gra-816	1	21	stroke	stroke	NOUN
gra-816	1	22	and	and	CCONJ
gra-816	1	23	renal	renal	PROPN
gra-816	1	24	failure.if	failure.if	PROPN
gra-816	1	25	untreated	untreate	VERB
gra-816	1	26	,	,	PUNCT
gra-816	1	27	approximately	approximately	ADV
gra-816	1	28	50	50	NUM
gra-816	1	29	%	%	NOUN
gra-816	1	30	of	of	ADP
gra-816	1	31	patients	patient	NOUN
gra-816	1	32	develop	develop	VERB
gra-816	1	33	heart	heart	NOUN
gra-816	1	34	disease,33	disease,33	PROPN
gra-816	1	35	%	%	NOUN
gra-816	1	36	develop	develop	NOUN
gra-816	1	37	stroke	stroke	NOUN
gra-816	1	38	,	,	PUNCT
gra-816	1	39	10	10	NUM
gra-816	1	40	-	-	SYM
gra-816	1	41	15	15	NUM
gra-816	1	42	%	%	NOUN
gra-816	1	43	develop	develop	VERB
gra-816	1	44	renal	renal	ADJ
gra-816	1	45	failure	failure	NOUN
gra-816	1	46	.	.	PUNCT
gra-816	2	1	microalbuminuria(ma	microalbuminuria(ma	PROPN
gra-816	2	2	)	)	PUNCT
gra-816	2	3	is	be	AUX
gra-816	2	4	dened	dene	VERB
gra-816	2	5	as	as	ADP
gra-816	2	6	urine	urine	NOUN
gra-816	2	7	albumin	albumin	ADJ
gra-816	2	8	excretion(uae	excretion(uae	NOUN
gra-816	2	9	)	)	PUNCT
gra-816	2	10	in	in	ADP
gra-816	2	11	the	the	DET
gra-816	2	12	range	range	NOUN
gra-816	2	13	of	of	ADP
gra-816	2	14	30	30	NUM
gra-816	2	15	-	-	SYM
gra-816	2	16	300	300	NUM
gra-816	2	17	mg/24h	mg/24h	NOUN
gra-816	2	18	,	,	PUNCT
gra-816	2	19	is	be	AUX
gra-816	2	20	seen	see	VERB
gra-816	2	21	in	in	ADP
gra-816	2	22	patients	patient	NOUN
gra-816	2	23	with	with	ADP
gra-816	2	24	established	establish	VERB
gra-816	2	25	hypertension	hypertension	NOUN
gra-816	2	26	and	and	CCONJ
gra-816	2	27	is	be	AUX
gra-816	2	28	a	a	DET
gra-816	2	29	predictor	predictor	NOUN
gra-816	2	30	of	of	ADP
gra-816	2	31	higher	high	ADJ
gra-816	2	32	risk	risk	NOUN
gra-816	2	33	of	of	ADP
gra-816	2	34	cardiovascular	cardiovascular	ADJ
gra-816	2	35	and	and	CCONJ
gra-816	2	36	renal	renal	ADJ
gra-816	2	37	dysfuntion.in	dysfuntion.in	X
gra-816	2	38	1976,parving	1976,parving	NUM
gra-816	2	39	et	et	NOUN
gra-816	2	40	al	al	PROPN
gra-816	2	41	highlighted	highlight	VERB
gra-816	2	42	the	the	DET
gra-816	2	43	relation	relation	NOUN
gra-816	2	44	between	between	ADP
gra-816	2	45	microalbuminuria	microalbuminuria	PROPN
gra-816	2	46	and	and	CCONJ
gra-816	2	47	severity	severity	NOUN
gra-816	2	48	of	of	ADP
gra-816	2	49	hypertension.leoncini	hypertension.leoncini	PROPN
gra-816	2	50	g	g	NOUN
gra-816	2	51	,	,	PUNCT
gra-816	2	52	studied	studied	ADJ
gra-816	2	53	association	association	NOUN
gra-816	2	54	of	of	ADP
gra-816	2	55	microalbuminuria	microalbuminuria	PROPN
gra-816	2	56	in	in	ADP
gra-816	2	57	345	345	NUM
gra-816	2	58	patients	patient	NOUN
gra-816	2	59	of	of	ADP
gra-816	2	60	asymptomatic	asymptomatic	ADJ
gra-816	2	61	hypertension	hypertension	NOUN
gra-816	2	62	and	and	CCONJ
gra-816	2	63	presence	presence	NOUN
gra-816	2	64	of	of	ADP
gra-816	2	65	subclinical	subclinical	ADJ
gra-816	2	66	organ	organ	NOUN
gra-816	2	67	damage.detection	damage.detection	PROPN
gra-816	2	68	of	of	ADP
gra-816	2	69	uae	uae	PROPN
gra-816	2	70	could	could	AUX
gra-816	2	71	be	be	AUX
gra-816	2	72	the	the	DET
gra-816	2	73	best	good	ADJ
gra-816	2	74	index	index	NOUN
gra-816	2	75	of	of	ADP
gra-816	2	76	an	an	DET
gra-816	2	77	increased	increase	VERB
gra-816	2	78	global	global	ADJ
gra-816	2	79	cardiovascular	cardiovascular	ADJ
gra-816	2	80	risk	risk	NOUN
gra-816	2	81	in	in	ADP
gra-816	2	82	a	a	DET
gra-816	2	83	given	give	VERB
gra-816	2	84	patient	patient	ADJ
gra-816	2	85	hypertension	hypertension	NOUN
gra-816	2	86	affects	affect	VERB
gra-816	2	87	the	the	DET
gra-816	2	88	heart	heart	NOUN
gra-816	2	89	by	by	ADP
gra-816	2	90	increasing	increase	VERB
gra-816	2	91	afterload	afterload	NOUN
gra-816	2	92	causing	cause	VERB
gra-816	2	93	the	the	DET
gra-816	2	94	lvh	lvh	PROPN
gra-816	2	95	(	(	PUNCT
gra-816	2	96	left	leave	VERB
gra-816	2	97	ventricular	ventricular	ADJ
gra-816	2	98	hypertrophy)and	hypertrophy)and	NOUN
gra-816	2	99	stiffening	stiffening	NOUN
gra-816	2	100	of	of	ADP
gra-816	2	101	the	the	DET
gra-816	2	102	left	left	ADJ
gra-816	2	103	ventricle	ventricle	NOUN
gra-816	2	104	ultimately	ultimately	ADV
gra-816	2	105	leading	lead	VERB
gra-816	2	106	to	to	PART
gra-816	2	107	increase	increase	VERB
gra-816	2	108	in	in	ADP
gra-816	2	109	the	the	DET
gra-816	2	110	left	left	ADJ
gra-816	2	111	ventricular	ventricular	NOUN
gra-816	2	112	mass.lvh	mass.lvh	NOUN
gra-816	2	113	is	be	AUX
gra-816	2	114	the	the	DET
gra-816	2	115	most	most	ADV
gra-816	2	116	common	common	ADJ
gra-816	2	117	abnormality	abnormality	NOUN
gra-816	2	118	in	in	ADP
gra-816	2	119	patients	patient	NOUN
gra-816	2	120	with	with	ADP
gra-816	2	121	hypertension	hypertension	NOUN
gra-816	2	122	and	and	CCONJ
gra-816	2	123	signicant	signicant	ADJ
gra-816	2	124	marker	marker	NOUN
gra-816	2	125	of	of	ADP
gra-816	2	126	subclinical	subclinical	ADJ
gra-816	2	127	cardiovascular	cardiovascular	ADJ
gra-816	2	128	disease.positive	disease.positive	ADJ
gra-816	2	129	correlation	correlation	NOUN
gra-816	2	130	between	between	ADP
gra-816	2	131	ma	ma	PROPN
gra-816	2	132	and	and	CCONJ
gra-816	2	133	lvh	lvh	PROPN
gra-816	2	134	has	have	AUX
gra-816	2	135	been	be	AUX
gra-816	2	136	documented	document	VERB
gra-816	2	137	in	in	ADP
gra-816	2	138	few	few	ADJ
gra-816	2	139	studies	study	NOUN
gra-816	2	140	,	,	PUNCT
gra-816	2	141	one	one	NUM
gra-816	2	142	such	such	ADJ
gra-816	2	143	by	by	ADP
gra-816	2	144	hitha	hitha	PROPN
gra-816	2	145	et	et	PROPN
gra-816	2	146	al	al	PROPN
gra-816	2	147	in	in	ADP
gra-816	2	148	south	south	PROPN
gra-816	2	149	india	india	PROPN
gra-816	2	150	studied	study	VERB
gra-816	2	151	relationship	relationship	NOUN
gra-816	2	152	between	between	ADP
gra-816	2	153	ma	ma	PROPN
gra-816	2	154	and	and	CCONJ
gra-816	2	155	target	target	VERB
gra-816	2	156	organ	organ	NOUN
gra-816	2	157	damage	damage	NOUN
gra-816	2	158	in	in	ADP
gra-816	2	159	hypertension.hypertension	hypertension.hypertension	NOUN
gra-816	2	160	accelerates	accelerate	VERB
gra-816	2	161	atherosclerosis	atherosclerosis	NOUN
gra-816	2	162	and	and	CCONJ
gra-816	2	163	also	also	ADV
gra-816	2	164	independently	independently	ADV
gra-816	2	165	causes	cause	VERB
gra-816	2	166	vascular	vascular	ADJ
gra-816	2	167	damage	damage	NOUN
gra-816	2	168	affecting	affect	VERB
gra-816	2	169	large	large	ADJ
gra-816	2	170	and	and	CCONJ
gra-816	2	171	small	small	ADJ
gra-816	2	172	vessels.this	vessels.this	DET
gra-816	2	173	study	study	NOUN
gra-816	2	174	was	be	AUX
gra-816	2	175	undertaken	undertake	VERB
gra-816	2	176	to	to	PART
gra-816	2	177	determine	determine	VERB
gra-816	2	178	the	the	DET
gra-816	2	179	prevalence	prevalence	NOUN
gra-816	2	180	of	of	ADP
gra-816	2	181	ma	ma	PROPN
gra-816	2	182	in	in	ADP
gra-816	2	183	hypertension	hypertension	NOUN
gra-816	2	184	and	and	CCONJ
gra-816	2	185	to	to	PART
gra-816	2	186	examine	examine	VERB
gra-816	2	187	its	its	PRON
gra-816	2	188	correlation	correlation	NOUN
gra-816	2	189	with	with	ADP
gra-816	2	190	severity	severity	NOUN
gra-816	2	191	of	of	ADP
gra-816	2	192	hypertension	hypertension	NOUN
gra-816	2	193	,	,	PUNCT
gra-816	2	194	lvh	lvh	PROPN
gra-816	2	195	.	.	PUNCT
gra-816	3	1	materials	material	NOUN
gra-816	3	2	and	and	CCONJ
gra-816	3	3	methods	method	NOUN
gra-816	3	4	study	study	VERB
gra-816	3	5	population	population	NOUN
gra-816	3	6	this	this	DET
gra-816	3	7	study	study	NOUN
gra-816	3	8	is	be	AUX
gra-816	3	9	conducted	conduct	VERB
gra-816	3	10	among	among	ADP
gra-816	3	11	100	100	NUM
gra-816	3	12	hypertensive(essential	hypertensive(essential	ADJ
gra-816	3	13	hypertension)patients	hypertension)patient	NOUN
gra-816	3	14	attending	attend	VERB
gra-816	3	15	general	general	ADJ
gra-816	3	16	medicine	medicine	NOUN
gra-816	3	17	department	department	PROPN
gra-816	3	18	outpatient	outpatient	NOUN
gra-816	3	19	clinic	clinic	NOUN
gra-816	3	20	and	and	CCONJ
gra-816	3	21	ward	ward	NOUN
gra-816	3	22	at	at	ADP
gra-816	3	23	sree	sree	PROPN
gra-816	3	24	balaji	balaji	PROPN
gra-816	3	25	medical	medical	PROPN
gra-816	3	26	college	college	PROPN
gra-816	3	27	and	and	CCONJ
gra-816	3	28	hospital	hospital	NOUN
gra-816	3	29	,	,	PUNCT
gra-816	3	30	chennai	chennai	PROPN
gra-816	3	31	collabarative	collabarative	PROPN
gra-816	3	32	deparments	deparment	NOUN
gra-816	3	33	:	:	PUNCT
gra-816	3	34	department	department	NOUN
gra-816	3	35	of	of	ADP
gra-816	3	36	cardiology	cardiology	NOUN
gra-816	3	37	,	,	PUNCT
gra-816	3	38	radiology	radiology	NOUN
gra-816	3	39	study	study	NOUN
gra-816	3	40	period	period	NOUN
gra-816	3	41	july	july	PROPN
gra-816	3	42	2018	2018	NUM
gra-816	3	43	to	to	ADP
gra-816	3	44	august	august	PROPN
gra-816	3	45	2019	2019	NUM
gra-816	3	46	ethical	ethical	ADJ
gra-816	3	47	concern	concern	NOUN
gra-816	3	48	the	the	DET
gra-816	3	49	project	project	NOUN
gra-816	3	50	was	be	AUX
gra-816	3	51	approved	approve	VERB
gra-816	3	52	by	by	ADP
gra-816	3	53	the	the	DET
gra-816	3	54	ethical	ethical	ADJ
gra-816	3	55	comitee	comitee	NOUN
gra-816	3	56	study	study	NOUN
gra-816	3	57	type	type	NOUN
gra-816	3	58	prospective	prospective	ADJ
gra-816	3	59	analysis	analysis	NOUN
gra-816	3	60	study	study	NOUN
gra-816	3	61	sample	sample	NOUN
gra-816	3	62	size	size	NOUN
gra-816	3	63	100	100	NUM
gra-816	3	64	cases	case	NOUN
gra-816	3	65	inclusion	inclusion	NOUN
gra-816	3	66	criteria	criterion	NOUN
gra-816	3	67	1	1	NUM
gra-816	3	68	.	.	X
gra-816	3	69	hypertensive	hypertensive	ADJ
gra-816	3	70	patients(both	patients(both	PROPN
gra-816	3	71	male	male	NOUN
gra-816	3	72	and	and	CCONJ
gra-816	3	73	female	female	NOUN
gra-816	3	74	)	)	PUNCT
gra-816	3	75	with	with	ADP
gra-816	3	76	bp>140/90mmhg	bp>140/90mmhg	NUM
gra-816	3	77	2	2	NUM
gra-816	3	78	.	.	X
gra-816	3	79	age	age	NOUN
gra-816	3	80	more	more	ADJ
gra-816	3	81	than	than	ADP
gra-816	3	82	30	30	NUM
gra-816	3	83	years	year	NOUN
gra-816	3	84	exclusion	exclusion	NOUN
gra-816	3	85	criteria	criterion	NOUN
gra-816	3	86	1	1	NUM
gra-816	3	87	.	.	PUNCT
gra-816	4	1	patients	patient	NOUN
gra-816	4	2	with	with	ADP
gra-816	4	3	renal	renal	ADJ
gra-816	4	4	disease	disease	NOUN
gra-816	4	5	2	2	NUM
gra-816	4	6	.	.	X
gra-816	5	1	diabetes	diabetes	NOUN
gra-816	5	2	mellitus	mellitus	NOUN
gra-816	5	3	3	3	X
gra-816	5	4	.	.	PUNCT
gra-816	5	5	chronic	chronic	ADJ
gra-816	5	6	heart	heart	NOUN
gra-816	5	7	failure	failure	NOUN
gra-816	5	8	4	4	NUM
gra-816	5	9	.	.	X
gra-816	5	10	ischemic	ischemic	ADJ
gra-816	5	11	heart	heart	NOUN
gra-816	5	12	disease	disease	NOUN
gra-816	5	13	5	5	NUM
gra-816	5	14	.	.	PUNCT
gra-816	5	15	cerbero	cerbero	ADJ
gra-816	5	16	vascular	vascular	ADJ
gra-816	5	17	disease	disease	NOUN
gra-816	5	18	6	6	NUM
gra-816	5	19	.	.	PUNCT
gra-816	6	1	patients	patient	NOUN
gra-816	6	2	with	with	ADP
gra-816	6	3	urinary	urinary	ADJ
gra-816	6	4	tract	tract	NOUN
gra-816	6	5	infections	infection	NOUN
gra-816	6	6	7	7	NUM
gra-816	6	7	.	.	PUNCT
gra-816	6	8	pregnancy	pregnancy	NOUN
gra-816	6	9	8	8	NUM
gra-816	6	10	.	.	PUNCT
gra-816	7	1	patients	patient	NOUN
gra-816	7	2	with	with	ADP
gra-816	7	3	obstructive	obstructive	ADJ
gra-816	7	4	uropathy	uropathy	ADJ
gra-816	7	5	conict	conict	PROPN
gra-816	7	6	of	of	ADP
gra-816	7	7	interest	interest	NOUN
gra-816	7	8	:	:	PUNCT
gra-816	7	9	nil	nil	ADJ
gra-816	7	10	financial	financial	ADJ
gra-816	7	11	support	support	NOUN
gra-816	7	12	:	:	PUNCT
gra-816	7	13	nil	nil	ADJ
gra-816	7	14	methodology	methodology	NOUN
gra-816	7	15	patients	patient	NOUN
gra-816	7	16	who	who	PRON
gra-816	7	17	were	be	AUX
gra-816	7	18	admitted	admit	VERB
gra-816	7	19	and	and	CCONJ
gra-816	7	20	attending	attend	VERB
gra-816	7	21	the	the	DET
gra-816	7	22	general	general	ADJ
gra-816	7	23	medicine	medicine	PROPN
gra-816	7	24	department	department	NOUN
gra-816	7	25	who	who	PRON
gra-816	7	26	fullled	fullle	VERB
gra-816	7	27	the	the	DET
gra-816	7	28	inclusion	inclusion	NOUN
gra-816	7	29	criteria	criterion	NOUN
gra-816	7	30	were	be	AUX
gra-816	7	31	included	include	VERB
gra-816	7	32	in	in	ADP
gra-816	7	33	the	the	DET
gra-816	7	34	study.patients	study.patient	NOUN
gra-816	7	35	fullling	fullle	VERB
gra-816	7	36	the	the	DET
gra-816	7	37	exclusion	exclusion	NOUN
gra-816	7	38	criteria	criterion	NOUN
gra-816	7	39	were	be	AUX
gra-816	7	40	excluded	exclude	VERB
gra-816	7	41	from	from	ADP
gra-816	7	42	the	the	DET
gra-816	7	43	study.investigations	study.investigation	NOUN
gra-816	7	44	were	be	AUX
gra-816	7	45	sent	send	VERB
gra-816	7	46	and	and	CCONJ
gra-816	7	47	study	study	NOUN
gra-816	7	48	of	of	ADP
gra-816	7	49	the	the	DET
gra-816	7	50	correlation	correlation	NOUN
gra-816	7	51	between	between	ADP
gra-816	7	52	microalbuminuria	microalbuminuria	PROPN
gra-816	7	53	and	and	CCONJ
gra-816	7	54	retinopathy	retinopathy	ADJ
gra-816	7	55	,	,	PUNCT
gra-816	7	56	lipid	lipid	NOUN
gra-816	7	57	profile	profile	NOUN
gra-816	7	58	in	in	ADP
gra-816	7	59	patients	patient	NOUN
gra-816	7	60	of	of	ADP
gra-816	7	61	essential	essential	ADJ
gra-816	7	62	hypertension	hypertension	NOUN
gra-816	7	63	original	original	ADJ
gra-816	7	64	research	research	NOUN
gra-816	7	65	paper	paper	NOUN
gra-816	7	66	dr.papaiah	dr.papaiah	NOUN
gra-816	7	67	nirmal	nirmal	ADJ
gra-816	7	68	pudota	pudota	ADJ
gra-816	7	69	m.b.b.s,(m.d	m.b.b.s,(m.d	PROPN
gra-816	7	70	)	)	PUNCT
gra-816	7	71	general	general	ADJ
gra-816	7	72	medicine	medicine	NOUN
gra-816	7	73	objective	objective	NOUN
gra-816	7	74	:	:	PUNCT
gra-816	7	75	to	to	PART
gra-816	7	76	detect	detect	VERB
gra-816	7	77	the	the	DET
gra-816	7	78	correlation	correlation	NOUN
gra-816	7	79	of	of	ADP
gra-816	7	80	microalbuminuria	microalbuminuria	PROPN
gra-816	7	81	in	in	ADP
gra-816	7	82	100	100	NUM
gra-816	7	83	hypertensive	hypertensive	ADJ
gra-816	7	84	patients	patient	NOUN
gra-816	7	85	with	with	ADP
gra-816	7	86	retinopathy	retinopathy	ADJ
gra-816	7	87	and	and	CCONJ
gra-816	7	88	lipid	lipid	NOUN
gra-816	7	89	prole	prole	PROPN
gra-816	7	90	methods	method	NOUN
gra-816	7	91	:	:	PUNCT
gra-816	7	92	we	we	PRON
gra-816	7	93	performed	perform	VERB
gra-816	7	94	a	a	DET
gra-816	7	95	prospective	prospective	ADJ
gra-816	7	96	analysis	analysis	NOUN
gra-816	7	97	study	study	NOUN
gra-816	7	98	of	of	ADP
gra-816	7	99	100	100	NUM
gra-816	7	100	patients	patient	NOUN
gra-816	7	101	visiting	visit	VERB
gra-816	7	102	balaji	balaji	PROPN
gra-816	7	103	medical	medical	PROPN
gra-816	7	104	college	college	PROPN
gra-816	7	105	and	and	CCONJ
gra-816	7	106	hospital	hospital	NOUN
gra-816	7	107	,	,	PUNCT
gra-816	7	108	chennai.inclusion	chennai.inclusion	NOUN
gra-816	7	109	criteria	criterion	NOUN
gra-816	7	110	:	:	PUNCT
gra-816	7	111	hypertensive	hypertensive	ADJ
gra-816	7	112	patients	patient	NOUN
gra-816	7	113	with	with	ADP
gra-816	7	114	bp>140/90	bp>140/90	PROPN
gra-816	7	115	mmhg	mmhg	NOUN
gra-816	7	116	and	and	CCONJ
gra-816	7	117	age	age	NOUN
gra-816	7	118	more	more	ADJ
gra-816	7	119	than	than	ADP
gra-816	7	120	30	30	NUM
gra-816	7	121	years.exclusion	years.exclusion	NUM
gra-816	7	122	criteria	criterion	NOUN
gra-816	7	123	:	:	PUNCT
gra-816	7	124	patients	patient	NOUN
gra-816	7	125	with	with	ADP
gra-816	7	126	renal	renal	ADJ
gra-816	7	127	disease	disease	NOUN
gra-816	7	128	,	,	PUNCT
gra-816	7	129	t2dm	t2dm	NOUN
gra-816	7	130	,	,	PUNCT
gra-816	7	131	ischemic	ischemic	ADJ
gra-816	7	132	heart	heart	NOUN
gra-816	7	133	disease	disease	NOUN
gra-816	7	134	,	,	PUNCT
gra-816	7	135	cva	cva	PROPN
gra-816	7	136	,	,	PUNCT
gra-816	7	137	pregnancy.microalbuminuria	pregnancy.microalbuminuria	PROPN
gra-816	7	138	was	be	AUX
gra-816	7	139	measured	measure	VERB
gra-816	7	140	using	use	VERB
gra-816	7	141	the	the	DET
gra-816	7	142	dip	dip	PROPN
gra-816	7	143	stick	stick	PROPN
gra-816	7	144	test	test	NOUN
gra-816	7	145	,	,	PUNCT
gra-816	7	146	dened	dene	VERB
gra-816	7	147	as	as	ADP
gra-816	7	148	having	have	VERB
gra-816	7	149	uae	uae	PROPN
gra-816	7	150	in	in	ADP
gra-816	7	151	the	the	DET
gra-816	7	152	range	range	NOUN
gra-816	7	153	of	of	ADP
gra-816	7	154	30	30	NUM
gra-816	7	155	-	-	SYM
gra-816	7	156	300mg/24h	300mg/24h	NUM
gra-816	7	157	results:100	results:100	NOUN
gra-816	7	158	patients	patient	NOUN
gra-816	7	159	were	be	AUX
gra-816	7	160	involved	involve	VERB
gra-816	7	161	in	in	ADP
gra-816	7	162	the	the	DET
gra-816	7	163	study	study	NOUN
gra-816	7	164	fullling	fullle	VERB
gra-816	7	165	the	the	DET
gra-816	7	166	criteria.30	criteria.30	NOUN
gra-816	7	167	out	out	ADP
gra-816	7	168	of	of	ADP
gra-816	7	169	100	100	NUM
gra-816	7	170	patients	patient	NOUN
gra-816	7	171	had	have	VERB
gra-816	7	172	microalbuminuria	microalbuminuria	ADJ
gra-816	7	173	.	.	PUNCT
gra-816	8	1	21	21	NUM
gra-816	8	2	males	male	NOUN
gra-816	8	3	out	out	ADP
gra-816	8	4	of	of	ADP
gra-816	8	5	45	45	NUM
gra-816	8	6	were	be	AUX
gra-816	8	7	found	find	VERB
gra-816	8	8	to	to	PART
gra-816	8	9	have	have	VERB
gra-816	8	10	microalbuminuria	microalbuminuria	NOUN
gra-816	8	11	and	and	CCONJ
gra-816	8	12	9	9	NUM
gra-816	8	13	out	out	ADP
gra-816	8	14	of	of	ADP
gra-816	8	15	25	25	NUM
gra-816	8	16	females	female	NOUN
gra-816	8	17	were	be	AUX
gra-816	8	18	found	find	VERB
gra-816	8	19	to	to	PART
gra-816	8	20	have	have	VERB
gra-816	8	21	microalbuminuria.serum	microalbuminuria.serum	ADJ
gra-816	8	22	levels	level	NOUN
gra-816	8	23	of	of	ADP
gra-816	8	24	cholesterol	cholesterol	NOUN
gra-816	8	25	,	,	PUNCT
gra-816	8	26	triglycerides	triglyceride	NOUN
gra-816	8	27	,	,	PUNCT
gra-816	8	28	and	and	CCONJ
gra-816	8	29	uric	uric	ADJ
gra-816	8	30	acid	acid	NOUN
gra-816	8	31	in	in	ADP
gra-816	8	32	patients	patient	NOUN
gra-816	8	33	with	with	ADP
gra-816	8	34	microalbuminuria	microalbuminuria	PROPN
gra-816	8	35	were	be	AUX
gra-816	8	36	higher	high	ADJ
gra-816	8	37	than	than	ADP
gra-816	8	38	the	the	DET
gra-816	8	39	levels	level	NOUN
gra-816	8	40	in	in	ADP
gra-816	8	41	those	those	PRON
gra-816	8	42	with	with	ADP
gra-816	8	43	normal	normal	ADJ
gra-816	8	44	uae(urine	uae(urine	ADJ
gra-816	8	45	albumin	albumin	ADJ
gra-816	8	46	excretion),and	excretion),and	PROPN
gra-816	8	47	hdl(high	hdl(high	ADJ
gra-816	8	48	density	density	NOUN
gra-816	8	49	lipid	lipid	NOUN
gra-816	8	50	)	)	PUNCT
gra-816	8	51	levels	level	NOUN
gra-816	8	52	in	in	ADP
gra-816	8	53	patients	patient	NOUN
gra-816	8	54	with	with	ADP
gra-816	8	55	ma(microalbuminuria)were	ma(microalbuminuria)were	ADJ
gra-816	8	56	lower	low	ADJ
gra-816	8	57	than	than	ADP
gra-816	8	58	levels	level	NOUN
gra-816	8	59	in	in	ADP
gra-816	8	60	patient	patient	NOUN
gra-816	8	61	with	with	ADP
gra-816	8	62	normal	normal	ADJ
gra-816	8	63	uae.on	uae.on	NUM
gra-816	8	64	performing	perform	VERB
gra-816	8	65	fundus	fundus	NOUN
gra-816	8	66	examination	examination	NOUN
gra-816	8	67	in	in	ADP
gra-816	8	68	the	the	DET
gra-816	8	69	study	study	NOUN
gra-816	8	70	patients	patient	NOUN
gra-816	8	71	,	,	PUNCT
gra-816	8	72	13	13	NUM
gra-816	8	73	out	out	ADP
gra-816	8	74	of	of	ADP
gra-816	8	75	22	22	NUM
gra-816	8	76	patients	patient	NOUN
gra-816	8	77	with	with	ADP
gra-816	8	78	grade	grade	PROPN
gra-816	8	79	ii	ii	PROPN
gra-816	8	80	retinopathy	retinopathy	NOUN
gra-816	8	81	had	have	VERB
gra-816	8	82	microalbuminuria	microalbuminuria	PROPN
gra-816	8	83	and	and	CCONJ
gra-816	8	84	8	8	NUM
gra-816	8	85	out	out	ADP
gra-816	8	86	of	of	ADP
gra-816	8	87	13	13	NUM
gra-816	8	88	with	with	ADP
gra-816	8	89	stage	stage	NOUN
gra-816	8	90	iii	iii	NUM
gra-816	8	91	retinopathy	retinopathy	NOUN
gra-816	8	92	had	have	VERB
gra-816	8	93	microalbuminuria	microalbuminuria	PROPN
gra-816	8	94	,	,	PUNCT
gra-816	8	95	5	5	NUM
gra-816	8	96	out	out	ADP
gra-816	8	97	of	of	ADP
gra-816	8	98	9	9	NUM
gra-816	8	99	with	with	ADP
gra-816	8	100	stage	stage	NOUN
gra-816	8	101	iv	iv	NUM
gra-816	8	102	had	have	VERB
gra-816	8	103	ma	ma	PROPN
gra-816	8	104	,	,	PUNCT
gra-816	8	105	and	and	CCONJ
gra-816	8	106	only	only	ADV
gra-816	8	107	2	2	NUM
gra-816	8	108	out	out	ADP
gra-816	8	109	of	of	ADP
gra-816	8	110	43	43	NUM
gra-816	8	111	patients	patient	NOUN
gra-816	8	112	with	with	ADP
gra-816	8	113	normal	normal	ADJ
gra-816	8	114	fundus	fundus	NOUN
gra-816	8	115	had	have	AUX
gra-816	8	116	ma.so	ma.so	NOUN
gra-816	8	117	,	,	PUNCT
gra-816	8	118	stage	stage	PROPN
gra-816	8	119	ii	ii	PROPN
gra-816	8	120	,	,	PUNCT
gra-816	8	121	iii	iii	NOUN
gra-816	8	122	,	,	PUNCT
gra-816	8	123	ivof	ivof	ADJ
gra-816	8	124	retinopathy	retinopathy	ADJ
gra-816	8	125	patients	patient	NOUN
gra-816	8	126	had	have	VERB
gra-816	8	127	more	more	ADJ
gra-816	8	128	frequency	frequency	NOUN
gra-816	8	129	of	of	ADP
gra-816	8	130	microalbuminuria	microalbuminuria	PROPN
gra-816	8	131	compared	compare	VERB
gra-816	8	132	to	to	ADP
gra-816	8	133	patients	patient	NOUN
gra-816	8	134	with	with	ADP
gra-816	8	135	normal	normal	ADJ
gra-816	8	136	fundus	fundus	NOUN
gra-816	8	137	.	.	PUNCT
gra-816	9	1	therefore	therefore	ADV
gra-816	9	2	screening	screen	VERB
gra-816	9	3	of	of	ADP
gra-816	9	4	fundus	fundus	NOUN
gra-816	9	5	is	be	AUX
gra-816	9	6	a	a	DET
gra-816	9	7	must	must	NOUN
gra-816	9	8	for	for	ADP
gra-816	9	9	patients	patient	NOUN
gra-816	9	10	having	have	VERB
gra-816	9	11	ma	ma	PROPN
gra-816	9	12	,	,	PUNCT
gra-816	9	13	so	so	SCONJ
gra-816	9	14	if	if	SCONJ
gra-816	9	15	we	we	PRON
gra-816	9	16	could	could	AUX
gra-816	9	17	detect	detect	VERB
gra-816	9	18	ma	ma	PROPN
gra-816	9	19	early	early	ADV
gra-816	9	20	,	,	PUNCT
gra-816	9	21	end	end	VERB
gra-816	9	22	organ	organ	NOUN
gra-816	9	23	damage	damage	NOUN
gra-816	9	24	could	could	AUX
gra-816	9	25	be	be	AUX
gra-816	9	26	prevented	prevent	VERB
gra-816	9	27	by	by	ADP
gra-816	9	28	appropriate	appropriate	ADJ
gra-816	9	29	clinical	clinical	ADJ
gra-816	9	30	management	management	NOUN
gra-816	9	31	conclusion	conclusion	NOUN
gra-816	9	32	:	:	PUNCT
gra-816	9	33	hypertension	hypertension	NOUN
gra-816	9	34	is	be	AUX
gra-816	9	35	one	one	NUM
gra-816	9	36	of	of	ADP
gra-816	9	37	the	the	DET
gra-816	9	38	most	most	ADV
gra-816	9	39	common	common	ADJ
gra-816	9	40	global	global	ADJ
gra-816	9	41	diseases	disease	NOUN
gra-816	9	42	causing	cause	VERB
gra-816	9	43	signicant	signicant	ADJ
gra-816	9	44	mortality	mortality	NOUN
gra-816	9	45	and	and	CCONJ
gra-816	9	46	morbidity.therefore	morbidity.therefore	ADP
gra-816	9	47	proper	proper	ADJ
gra-816	9	48	screening	screening	NOUN
gra-816	9	49	and	and	CCONJ
gra-816	9	50	assessment	assessment	NOUN
gra-816	9	51	is	be	AUX
gra-816	9	52	required	require	VERB
gra-816	9	53	to	to	PART
gra-816	9	54	identify	identify	VERB
gra-816	9	55	patients	patient	NOUN
gra-816	9	56	at	at	ADP
gra-816	9	57	risk.patients	risk.patient	NOUN
gra-816	9	58	with	with	ADP
gra-816	9	59	microalbuminuria	microalbuminuria	PROPN
gra-816	9	60	have	have	AUX
gra-816	9	61	increased	increase	VERB
gra-816	9	62	chances	chance	NOUN
gra-816	9	63	of	of	ADP
gra-816	9	64	developing	develop	VERB
gra-816	9	65	retinopathy	retinopathy	NOUN
gra-816	9	66	compared	compare	VERB
gra-816	9	67	to	to	ADP
gra-816	9	68	those	those	DET
gra-816	9	69	without.so	without.so	PROPN
gra-816	9	70	,	,	PUNCT
gra-816	9	71	screening	screen	VERB
gra-816	9	72	for	for	ADP
gra-816	9	73	microalbuminuria	microalbuminuria	PROPN
gra-816	9	74	must	must	AUX
gra-816	9	75	be	be	AUX
gra-816	9	76	considered	consider	VERB
gra-816	9	77	to	to	PART
gra-816	9	78	be	be	AUX
gra-816	9	79	part	part	NOUN
gra-816	9	80	of	of	ADP
gra-816	9	81	initial	initial	ADJ
gra-816	9	82	work	work	NOUN
gra-816	9	83	up	up	ADP
gra-816	9	84	in	in	ADP
gra-816	9	85	every	every	DET
gra-816	9	86	hypertensive	hypertensive	ADJ
gra-816	9	87	patient	patient	NOUN
gra-816	9	88	and	and	CCONJ
gra-816	9	89	those	those	PRON
gra-816	9	90	with	with	ADP
gra-816	9	91	ma	ma	PROPN
gra-816	9	92	must	must	AUX
gra-816	9	93	be	be	AUX
gra-816	9	94	screened	screen	VERB
gra-816	9	95	regularly	regularly	ADV
gra-816	9	96	for	for	ADP
gra-816	9	97	fundus	fundus	NOUN
gra-816	9	98	along	along	ADP
gra-816	9	99	with	with	ADP
gra-816	9	100	appropriate	appropriate	ADJ
gra-816	9	101	clinical	clinical	ADJ
gra-816	9	102	management	management	NOUN
gra-816	9	103	.	.	PUNCT
gra-816	10	1	abstract	abstract	ADJ
gra-816	10	2	keywords	keyword	NOUN
gra-816	10	3	:	:	PUNCT
gra-816	10	4	volume-8	volume-8	NUM
gra-816	10	5	,	,	PUNCT
gra-816	10	6	issue-11	issue-11	PROPN
gra-816	10	7	,	,	PUNCT
gra-816	10	8	november-2019	november-2019	ADJ
gra-816	10	9	•	•	NOUN
gra-816	10	10	print	print	NOUN
gra-816	10	11	issn	issn	PROPN
gra-816	10	12	no	no	NOUN
gra-816	10	13	.	.	PROPN
gra-816	10	14	2277	2277	NUM
gra-816	10	15	8160	8160	NUM
gra-816	10	16	•	•	NOUN
gra-816	10	17	doi	doi	NOUN
gra-816	10	18	:	:	PUNCT
gra-816	10	19	10.36106	10.36106	NUM
gra-816	10	20	/	/	SYM
gra-816	10	21	gjra	gjra	NOUN
gra-816	10	22	36	36	NUM
gra-816	10	23	x	x	NOUN
gra-816	10	24	gjra	gjra	PROPN
gra-816	10	25	global	global	ADJ
gra-816	10	26	journal	journal	PROPN
gra-816	10	27	for	for	ADP
gra-816	10	28	research	research	NOUN
gra-816	10	29	analysis	analysis	NOUN
gra-816	10	30	corellations	corellation	NOUN
gra-816	10	31	were	be	AUX
gra-816	10	32	made	make	VERB
gra-816	10	33	accordingly	accordingly	ADV
gra-816	10	34	labaratory	labaratory	ADJ
gra-816	10	35	investigations	investigation	NOUN
gra-816	10	36	1	1	NUM
gra-816	10	37	.	.	X
gra-816	11	1	clinial	clinial	ADJ
gra-816	11	2	blood	blood	NOUN
gra-816	11	3	pressure	pressure	NOUN
gra-816	11	4	was	be	AUX
gra-816	11	5	recorded	record	VERB
gra-816	11	6	using	use	VERB
gra-816	11	7	sphygmo	sphygmo	ADJ
gra-816	11	8	manometer	manometer	NOUN
gra-816	11	9	with	with	ADP
gra-816	11	10	standard	standard	ADJ
gra-816	11	11	size	size	NOUN
gra-816	11	12	cuff	cuff	NOUN
gra-816	11	13	on	on	ADP
gra-816	11	14	2	2	NUM
gra-816	11	15	to	to	PART
gra-816	11	16	3	3	NUM
gra-816	11	17	occasions	occasion	NOUN
gra-816	11	18	atleast	atleast	ADV
gra-816	11	19	to	to	ADP
gra-816	11	20	10	10	NUM
gra-816	11	21	min	min	NOUN
gra-816	11	22	apart	apart	ADV
gra-816	11	23	.	.	PUNCT
gra-816	12	1	2	2	X
gra-816	12	2	.	.	X
gra-816	12	3	microalbuminuria	microalbuminuria	PROPN
gra-816	12	4	estimation	estimation	NOUN
gra-816	12	5	was	be	AUX
gra-816	12	6	done	do	VERB
gra-816	12	7	using	use	VERB
gra-816	12	8	immuno	immuno	ADJ
gra-816	12	9	turbidemetric	turbidemetric	NOUN
gra-816	12	10	two	two	NUM
gra-816	12	11	point	point	NOUN
gra-816	12	12	assay	assay	VERB
gra-816	12	13	when	when	SCONJ
gra-816	12	14	a	a	DET
gra-816	12	15	urine	urine	NOUN
gra-816	12	16	specimen	speciman	NOUN
gra-816	12	17	is	be	AUX
gra-816	12	18	mixed	mix	VERB
gra-816	12	19	with	with	ADP
gra-816	12	20	the	the	DET
gra-816	12	21	reagents	reagent	NOUN
gra-816	12	22	,	,	PUNCT
gra-816	12	23	albumin	albumin	NOUN
gra-816	12	24	in	in	ADP
gra-816	12	25	the	the	DET
gra-816	12	26	specimen	speciman	NOUN
gra-816	12	27	combines	combine	VERB
gra-816	12	28	with	with	ADP
gra-816	12	29	the	the	DET
gra-816	12	30	anti	anti	PROPN
gra-816	12	31	human	human	ADJ
gra-816	12	32	albumin	albumin	ADJ
gra-816	12	33	antibody	antibody	NOUN
gra-816	12	34	in	in	ADP
gra-816	12	35	the	the	DET
gra-816	12	36	reagent	reagent	NOUN
gra-816	12	37	to	to	PART
gra-816	12	38	yield	yield	VERB
gra-816	12	39	an	an	DET
gra-816	12	40	insoluble	insoluble	ADJ
gra-816	12	41	aggregate	aggregate	NOUN
gra-816	12	42	that	that	PRON
gra-816	12	43	causes	cause	VERB
gra-816	12	44	increased	increase	VERB
gra-816	12	45	turbidity	turbidity	NOUN
gra-816	12	46	in	in	ADP
gra-816	12	47	the	the	DET
gra-816	12	48	solution.the	solution.the	DET
gra-816	12	49	absorbance	absorbance	NOUN
gra-816	12	50	of	of	ADP
gra-816	12	51	the	the	DET
gra-816	12	52	reaction	reaction	NOUN
gra-816	12	53	turbidity	turbidity	NOUN
gra-816	12	54	is	be	AUX
gra-816	12	55	proportional	proportional	ADJ
gra-816	12	56	to	to	ADP
gra-816	12	57	the	the	DET
gra-816	12	58	concentration	concentration	NOUN
gra-816	12	59	of	of	ADP
gra-816	12	60	albumin	albumin	NOUN
gra-816	12	61	in	in	ADP
gra-816	12	62	the	the	DET
gra-816	12	63	specimen	speciman	NOUN
gra-816	12	64	,	,	PUNCT
gra-816	12	65	and	and	CCONJ
gra-816	12	66	can	can	AUX
gra-816	12	67	be	be	AUX
gra-816	12	68	measured	measure	VERB
gra-816	12	69	optically	optically	ADV
gra-816	12	70	using	use	VERB
gra-816	12	71	spectrophotometer	spectrophotometer	NOUN
gra-816	12	72	.	.	PUNCT
gra-816	13	1	3	3	X
gra-816	13	2	.	.	X
gra-816	13	3	fasting	fast	VERB
gra-816	13	4	lipid	lipid	NOUN
gra-816	13	5	prole	prole	PROPN
gra-816	13	6	4	4	NUM
gra-816	13	7	.	.	PUNCT
gra-816	13	8	fundus	fundus	NOUN
gra-816	13	9	examination	examination	NOUN
gra-816	13	10	by	by	ADP
gra-816	13	11	opthalmoscope	opthalmoscope	NOUN
gra-816	13	12	results	result	NOUN
gra-816	13	13	frequency	frequency	NOUN
gra-816	13	14	of	of	ADP
gra-816	13	15	ma	ma	PROPN
gra-816	13	16	in	in	ADP
gra-816	13	17	100	100	NUM
gra-816	13	18	essential	essential	ADJ
gra-816	13	19	hypertensive	hypertensive	ADJ
gra-816	13	20	patients	patient	NOUN
gra-816	13	21	is	be	AUX
gra-816	13	22	found	find	VERB
gra-816	13	23	to	to	PART
gra-816	13	24	be	be	AUX
gra-816	13	25	30	30	NUM
gra-816	13	26	%	%	NOUN
gra-816	13	27	frequency	frequency	NOUN
gra-816	13	28	of	of	ADP
gra-816	13	29	microalbuminuria	microalbuminuria	PROPN
gra-816	13	30	in	in	ADP
gra-816	13	31	100	100	NUM
gra-816	13	32	hyperte	hyperte	NOUN
gra-816	13	33	nsive	nsive	ADJ
gra-816	13	34	patients-30	patients-30	PROPN
gra-816	13	35	%	%	NOUN
gra-816	13	36	relation	relation	NOUN
gra-816	13	37	of	of	ADP
gra-816	13	38	microalbuminuria	microalbuminuria	PROPN
gra-816	13	39	with	with	ADP
gra-816	13	40	age	age	NOUN
gra-816	13	41	mean	mean	VERB
gra-816	13	42	age	age	NOUN
gra-816	13	43	of	of	ADP
gra-816	13	44	the	the	DET
gra-816	13	45	patients	patient	NOUN
gra-816	13	46	is	be	AUX
gra-816	13	47	around	around	ADV
gra-816	13	48	60	60	NUM
gra-816	13	49	with	with	ADP
gra-816	13	50	ma	ma	PROPN
gra-816	13	51	and	and	CCONJ
gra-816	13	52	without	without	ADP
gra-816	13	53	ma	ma	PROPN
gra-816	13	54	is	be	AUX
gra-816	13	55	around	around	ADP
gra-816	13	56	45.thus	45.thus	NUM
gra-816	13	57	,	,	PUNCT
gra-816	13	58	age	age	NOUN
gra-816	13	59	showed	show	VERB
gra-816	13	60	a	a	DET
gra-816	13	61	signicant	signicant	ADJ
gra-816	13	62	positive	positive	ADJ
gra-816	13	63	correlation	correlation	NOUN
gra-816	13	64	with	with	ADP
gra-816	13	65	ma	ma	PROPN
gra-816	13	66	in	in	ADP
gra-816	13	67	the	the	DET
gra-816	13	68	study.patients	study.patient	NOUN
gra-816	13	69	with	with	ADP
gra-816	13	70	higher	high	ADJ
gra-816	13	71	age	age	NOUN
gra-816	13	72	group	group	NOUN
gra-816	13	73	60	60	NUM
gra-816	13	74	and	and	CCONJ
gra-816	13	75	above	above	ADP
gra-816	13	76	patients	patient	NOUN
gra-816	13	77	have	have	AUX
gra-816	13	78	increased	increase	VERB
gra-816	13	79	prevalence	prevalence	NOUN
gra-816	13	80	of	of	ADP
gra-816	13	81	miccroalbuminuria.studies	miccroalbuminuria.studie	NOUN
gra-816	13	82	support	support	VERB
gra-816	13	83	this	this	DET
gra-816	13	84	characteristic	characteristic	NOUN
gra-816	13	85	that	that	SCONJ
gra-816	13	86	ma	ma	PROPN
gra-816	13	87	prevalence	prevalence	NOUN
gra-816	13	88	increases	increase	VERB
gra-816	13	89	with	with	ADP
gra-816	13	90	age.in	age.in	NOUN
gra-816	13	91	our	our	PRON
gra-816	13	92	study	study	NOUN
gra-816	13	93	we	we	PRON
gra-816	13	94	found	find	VERB
gra-816	13	95	ma	ma	PROPN
gra-816	13	96	to	to	PART
gra-816	13	97	be	be	AUX
gra-816	13	98	present	present	ADJ
gra-816	13	99	in	in	ADP
gra-816	13	100	66	66	NUM
gra-816	13	101	%	%	NOUN
gra-816	13	102	of	of	ADP
gra-816	13	103	the	the	DET
gra-816	13	104	males	male	NOUN
gra-816	13	105	and	and	CCONJ
gra-816	13	106	some	some	DET
gra-816	13	107	support	support	VERB
gra-816	13	108	more	more	ADJ
gra-816	13	109	prevalence	prevalence	NOUN
gra-816	13	110	in	in	ADP
gra-816	13	111	males	male	NOUN
gra-816	13	112	but	but	CCONJ
gra-816	13	113	some	some	DET
gra-816	13	114	studies	study	NOUN
gra-816	13	115	do	do	AUX
gra-816	13	116	not	not	PART
gra-816	13	117	support	support	VERB
gra-816	13	118	this	this	PRON
gra-816	13	119	correlation.as	correlation.as	PRON
gra-816	14	1	such	such	ADJ
gra-816	14	2	,	,	PUNCT
gra-816	14	3	therefore	therefore	ADV
gra-816	14	4	sex	sex	NOUN
gra-816	14	5	of	of	ADP
gra-816	14	6	the	the	DET
gra-816	14	7	patient	patient	NOUN
gra-816	14	8	does	do	AUX
gra-816	14	9	n't	not	PART
gra-816	14	10	correlate	correlate	VERB
gra-816	14	11	with	with	ADP
gra-816	14	12	increased	increase	VERB
gra-816	14	13	prevalence	prevalence	NOUN
gra-816	14	14	of	of	ADP
gra-816	14	15	ma(microalbuminuria	ma(microalbuminuria	NOUN
gra-816	14	16	)	)	PUNCT
gra-816	14	17	fundus	fundus	NOUN
gra-816	14	18	changes	change	NOUN
gra-816	14	19	and	and	CCONJ
gra-816	14	20	microalbuminuria	microalbuminuria	ADJ
gra-816	14	21	p	p	NOUN
gra-816	14	22	value	value	NOUN
gra-816	14	23	at	at	ADP
gra-816	14	24	0.0005	0.0005	NUM
gra-816	14	25	.highly	.highly	ADV
gra-816	14	26	significant	significant	ADJ
gra-816	14	27	totally	totally	ADV
gra-816	14	28	out	out	ADP
gra-816	14	29	of	of	ADP
gra-816	14	30	the	the	DET
gra-816	14	31	30	30	NUM
gra-816	14	32	patients	patient	NOUN
gra-816	14	33	with	with	ADP
gra-816	14	34	microalbu	microalbu	PROPN
gra-816	14	35	minuria	minuria	PROPN
gra-816	14	36	13	13	NUM
gra-816	14	37	belong	belong	VERB
gra-816	14	38	to	to	ADP
gra-816	14	39	stage	stage	NOUN
gra-816	14	40	ii	ii	PROPN
gra-816	14	41	retinopathy	retinopathy	NOUN
gra-816	14	42	and	and	CCONJ
gra-816	14	43	8	8	NUM
gra-816	14	44	belong	belong	VERB
gra-816	14	45	to	to	ADP
gra-816	14	46	stage	stage	NOUN
gra-816	14	47	iii	iii	NUM
gra-816	14	48	retinopathy	retinopathy	NOUN
gra-816	14	49	and	and	CCONJ
gra-816	14	50	5	5	NUM
gra-816	14	51	to	to	PART
gra-816	14	52	stage	stage	VERB
gra-816	14	53	iv	iv	NUM
gra-816	14	54	retinopathy.only	retinopathy.only	ADV
gra-816	14	55	4,2	4,2	NUM
gra-816	14	56	from	from	ADP
gra-816	14	57	stage	stage	NOUN
gra-816	14	58	i(out	i(out	NOUN
gra-816	14	59	of	of	ADP
gra-816	14	60	13	13	NUM
gra-816	14	61	)	)	PUNCT
gra-816	14	62	and	and	CCONJ
gra-816	15	1	2	2	NUM
gra-816	15	2	f	f	NOUN
gra-816	15	3	r	r	NOUN
gra-816	15	4	o	o	NOUN
gra-816	15	5	m	m	VERB
gra-816	15	6	n	n	ADV
gra-816	15	7	o	o	NOUN
gra-816	15	8	r	r	NOUN
gra-816	15	9	m	m	VERB
gra-816	15	10	a	a	DET
gra-816	15	11	l	l	NOUN
gra-816	15	12	f	f	PUNCT
gra-816	15	13	u	u	PROPN
gra-816	15	14	n	n	PROPN
gra-816	15	15	d	d	X
gra-816	15	16	u	u	X
gra-816	15	17	s	s	X
gra-816	15	18	(	(	PUNCT
gra-816	15	19	o	o	NOUN
gra-816	15	20	u	u	NOUN
gra-816	15	21	t	t	X
gra-816	15	22	o	o	X
gra-816	15	23	f	f	PROPN
gra-816	15	24	4	4	NUM
gra-816	15	25	3	3	NUM
gra-816	15	26	)	)	PUNCT
gra-816	15	27	h	h	NOUN
gra-816	15	28	av	av	NOUN
gra-816	15	29	e	e	PROPN
gra-816	15	30	microalbuminuria	microalbuminuria	ADJ
gra-816	15	31	correlation	correlation	NOUN
gra-816	15	32	between	between	ADP
gra-816	15	33	ma	ma	PROPN
gra-816	15	34	and	and	CCONJ
gra-816	15	35	lipid	lipid	NOUN
gra-816	15	36	prole	prole	PROPN
gra-816	15	37	comparision	comparision	NOUN
gra-816	15	38	between	between	ADP
gra-816	15	39	lipid	lipid	NOUN
gra-816	15	40	profile	profile	NOUN
gra-816	15	41	and	and	CCONJ
gra-816	15	42	ma	ma	PROPN
gra-816	15	43	p	p	PROPN
gra-816	15	44	value	value	NOUN
gra-816	15	45	0.0005	0.0005	NUM
gra-816	15	46	highly	highly	ADV
gra-816	15	47	significant	significant	ADJ
gra-816	15	48	f	f	ADJ
gra-816	15	49	-	-	PUNCT
gra-816	15	50	favourable	favourable	ADJ
gra-816	15	51	lipid	lipid	NOUN
gra-816	15	52	prole	prole	PROPN
gra-816	15	53	nf	nf	PROPN
gra-816	15	54	-	-	PUNCT
gra-816	15	55	not	not	PART
gra-816	15	56	favourable	favourable	ADJ
gra-816	15	57	lipid	lipid	NOUN
gra-816	15	58	prole	prole	PROPN
gra-816	15	59	discussion	discussion	NOUN
gra-816	15	60	hypertension	hypertension	NOUN
gra-816	15	61	is	be	AUX
gra-816	15	62	one	one	NUM
gra-816	15	63	of	of	ADP
gra-816	15	64	the	the	DET
gra-816	15	65	most	most	ADV
gra-816	15	66	global	global	ADJ
gra-816	15	67	diseases	disease	NOUN
gra-816	15	68	causing	cause	VERB
gra-816	15	69	burden	burden	NOUN
gra-816	15	70	worldwide	worldwide	ADV
gra-816	15	71	and	and	CCONJ
gra-816	15	72	is	be	AUX
gra-816	15	73	one	one	NUM
gra-816	15	74	of	of	ADP
gra-816	15	75	the	the	DET
gra-816	15	76	most	most	ADV
gra-816	15	77	common	common	ADJ
gra-816	15	78	cause	cause	NOUN
gra-816	15	79	of	of	ADP
gra-816	15	80	morbidity	morbidity	NOUN
gra-816	15	81	and	and	CCONJ
gra-816	15	82	mortality.along	mortality.along	NOUN
gra-816	15	83	with	with	ADP
gra-816	15	84	diabetes	diabetes	NOUN
gra-816	15	85	,	,	PUNCT
gra-816	15	86	it	it	PRON
gra-816	15	87	is	be	AUX
gra-816	15	88	the	the	DET
gra-816	15	89	most	most	ADV
gra-816	15	90	common	common	ADJ
gra-816	15	91	disease	disease	NOUN
gra-816	15	92	affecting	affect	VERB
gra-816	15	93	the	the	DET
gra-816	15	94	end	end	NOUN
gra-816	15	95	organs	organ	NOUN
gra-816	15	96	of	of	ADP
gra-816	15	97	the	the	DET
gra-816	15	98	body.hypertension	body.hypertension	NOUN
gra-816	15	99	affects	affect	VERB
gra-816	15	100	almost	almost	ADV
gra-816	15	101	every	every	PRON
gra-816	15	102	organ	organ	NOUN
gra-816	15	103	in	in	ADP
gra-816	15	104	the	the	DET
gra-816	15	105	body.in	body.in	PROPN
gra-816	15	106	order	order	NOUN
gra-816	15	107	to	to	PART
gra-816	15	108	detect	detect	VERB
gra-816	15	109	the	the	DET
gra-816	15	110	end	end	NOUN
gra-816	15	111	organ	organ	NOUN
gra-816	15	112	damage	damage	NOUN
gra-816	15	113	,	,	PUNCT
gra-816	15	114	patients	patient	NOUN
gra-816	15	115	usually	usually	ADV
gra-816	15	116	will	will	AUX
gra-816	15	117	not	not	PART
gra-816	15	118	present	present	VERB
gra-816	15	119	with	with	ADP
gra-816	15	120	symptoms	symptom	NOUN
gra-816	15	121	unless	unless	SCONJ
gra-816	15	122	severely	severely	ADV
gra-816	15	123	affected.mostly	affected.mostly	ADV
gra-816	15	124	they	they	PRON
gra-816	15	125	remain	remain	VERB
gra-816	15	126	asymptomatic	asymptomatic	ADJ
gra-816	15	127	.so	.so	PUNCT
gra-816	15	128	to	to	PART
gra-816	15	129	know	know	VERB
gra-816	15	130	how	how	SCONJ
gra-816	15	131	can	can	AUX
gra-816	15	132	we	we	PRON
gra-816	15	133	detect	detect	VERB
gra-816	15	134	the	the	DET
gra-816	15	135	damage	damage	NOUN
gra-816	15	136	early.so	early.so	NUM
gra-816	15	137	that	that	SCONJ
gra-816	15	138	we	we	PRON
gra-816	15	139	can	can	AUX
gra-816	15	140	prevent	prevent	VERB
gra-816	15	141	the	the	DET
gra-816	15	142	complications	complication	NOUN
gra-816	15	143	of	of	ADP
gra-816	15	144	hypertension.100	hypertension.100	ADJ
gra-816	15	145	patients	patient	NOUN
gra-816	15	146	with	with	ADP
gra-816	15	147	essential	essential	ADJ
gra-816	15	148	hypertension	hypertension	NOUN
gra-816	15	149	presenting	present	VERB
gra-816	15	150	to	to	ADP
gra-816	15	151	our	our	PRON
gra-816	15	152	hospital	hospital	NOUN
gra-816	15	153	were	be	AUX
gra-816	15	154	looked	look	VERB
gra-816	15	155	for	for	ADP
gra-816	15	156	age	age	NOUN
gra-816	15	157	,	,	PUNCT
gra-816	15	158	sex	sex	NOUN
gra-816	15	159	,	,	PUNCT
gra-816	15	160	duration	duration	NOUN
gra-816	15	161	of	of	ADP
gra-816	15	162	hypertension	hypertension	NOUN
gra-816	15	163	,	,	PUNCT
gra-816	15	164	ecg	ecg	PROPN
gra-816	15	165	lipid	lipid	PROPN
gra-816	15	166	prole	prole	PROPN
gra-816	15	167	and	and	CCONJ
gra-816	15	168	were	be	AUX
gra-816	15	169	screened	screen	VERB
gra-816	15	170	for	for	ADP
gra-816	15	171	the	the	DET
gra-816	15	172	end	end	NOUN
gra-816	15	173	volume-8	volume-8	NUM
gra-816	15	174	,	,	PUNCT
gra-816	15	175	issue-11	issue-11	PROPN
gra-816	15	176	,	,	PUNCT
gra-816	15	177	november-2019	november-2019	ADJ
gra-816	15	178	•	•	NOUN
gra-816	15	179	print	print	NOUN
gra-816	15	180	issn	issn	PROPN
gra-816	15	181	no	no	NOUN
gra-816	15	182	.	.	PROPN
gra-816	16	1	2277	2277	NUM
gra-816	16	2	8160	8160	NUM
gra-816	16	3	•	•	NOUN
gra-816	16	4	doi	doi	NOUN
gra-816	16	5	:	:	PUNCT
gra-816	16	6	10.36106	10.36106	NUM
gra-816	16	7	/	/	SYM
gra-816	16	8	gjra	gjra	ADJ
gra-816	16	9	microalbuminuria	microalbuminuria	ADJ
gra-816	16	10	frequency	frequency	NOUN
gra-816	16	11	percent	percent	NOUN
gra-816	16	12	a	a	DET
gra-816	16	13	70	70	NUM
gra-816	16	14	70.0	70.0	NUM
gra-816	16	15	p	p	NOUN
gra-816	16	16	30	30	NUM
gra-816	16	17	30	30	NUM
gra-816	16	18	total	total	NOUN
gra-816	16	19	100	100	NUM
gra-816	16	20	100	100	NUM
gra-816	16	21	age	age	NOUN
gra-816	16	22	count	count	NOUN
gra-816	16	23	%	%	NOUN
gra-816	16	24	ma	ma	PROPN
gra-816	16	25	total	total	NOUN
gra-816	16	26	a	a	DET
gra-816	16	27	p	p	NOUN
gra-816	16	28	upto	upto	NOUN
gra-816	16	29	40	40	NUM
gra-816	16	30	years	year	NOUN
gra-816	16	31	count	count	VERB
gra-816	16	32	%	%	NOUN
gra-816	16	33	9	9	NUM
gra-816	16	34	12.9	12.9	NUM
gra-816	16	35	%	%	NOUN
gra-816	16	36	0	0	NUM
gra-816	16	37	0.0	0.0	NUM
gra-816	16	38	%	%	NOUN
gra-816	16	39	9	9	NUM
gra-816	16	40	9.0	9.0	NUM
gra-816	16	41	%	%	NOUN
gra-816	16	42	41	41	NUM
gra-816	16	43	-	-	SYM
gra-816	16	44	50	50	NUM
gra-816	16	45	years	year	NOUN
gra-816	16	46	count	count	VERB
gra-816	16	47	%	%	NOUN
gra-816	16	48	14	14	NUM
gra-816	16	49	20.0	20.0	NUM
gra-816	16	50	%	%	NOUN
gra-816	16	51	7	7	NUM
gra-816	16	52	23.3	23.3	NUM
gra-816	16	53	%	%	NOUN
gra-816	16	54	21	21	NUM
gra-816	16	55	21	21	NUM
gra-816	16	56	%	%	NOUN
gra-816	16	57	51	51	NUM
gra-816	16	58	-	-	SYM
gra-816	16	59	60	60	NUM
gra-816	16	60	years	year	NOUN
gra-816	16	61	count	count	VERB
gra-816	16	62	%	%	NOUN
gra-816	16	63	19	19	NUM
gra-816	16	64	27.1	27.1	NUM
gra-816	16	65	%	%	NOUN
gra-816	16	66	9	9	NUM
gra-816	16	67	30.0	30.0	NUM
gra-816	16	68	%	%	NOUN
gra-816	16	69	28	28	NUM
gra-816	16	70	28.0	28.0	NUM
gra-816	16	71	%	%	NOUN
gra-816	16	72	61	61	NUM
gra-816	16	73	-	-	SYM
gra-816	16	74	70	70	NUM
gra-816	16	75	years	year	NOUN
gra-816	16	76	count	count	VERB
gra-816	16	77	%	%	NOUN
gra-816	16	78	20	20	NUM
gra-816	16	79	28.6	28.6	NUM
gra-816	16	80	%	%	NOUN
gra-816	16	81	10	10	NUM
gra-816	16	82	33.3	33.3	NUM
gra-816	16	83	%	%	NOUN
gra-816	16	84	30	30	NUM
gra-816	16	85	30.0	30.0	NUM
gra-816	16	86	%	%	NOUN
gra-816	16	87	above	above	ADP
gra-816	16	88	7o	7o	NUM
gra-816	16	89	years	year	NOUN
gra-816	16	90	count	count	VERB
gra-816	16	91	%	%	NOUN
gra-816	16	92	8	8	NUM
gra-816	16	93	11.4	11.4	NUM
gra-816	16	94	%	%	NOUN
gra-816	16	95	4	4	NUM
gra-816	16	96	13.3	13.3	NUM
gra-816	16	97	%	%	NOUN
gra-816	16	98	12	12	NUM
gra-816	16	99	12	12	NUM
gra-816	16	100	%	%	NOUN
gra-816	16	101	total	total	ADJ
gra-816	16	102	count	count	NOUN
gra-816	16	103	%	%	NOUN
gra-816	16	104	70	70	NUM
gra-816	16	105	100.0	100.0	NUM
gra-816	16	106	%	%	NOUN
gra-816	16	107	30	30	NUM
gra-816	16	108	100.0	100.0	NUM
gra-816	16	109	%	%	NOUN
gra-816	16	110	100	100	NUM
gra-816	16	111	100.0	100.0	NUM
gra-816	16	112	%	%	NOUN
gra-816	17	1	fundus	fundus	NOUN
gra-816	17	2	count	count	NOUN
gra-816	17	3	%	%	NOUN
gra-816	17	4	ma	ma	PROPN
gra-816	17	5	total	total	NOUN
gra-816	17	6	a	a	DET
gra-816	17	7	p	p	X
gra-816	18	1	i	i	PRON
gra-816	18	2	count	count	VERB
gra-816	18	3	%	%	NOUN
gra-816	18	4	11	11	NUM
gra-816	18	5	15.7	15.7	NUM
gra-816	18	6	%	%	NOUN
gra-816	18	7	2	2	NUM
gra-816	18	8	6.7	6.7	NUM
gra-816	18	9	%	%	NOUN
gra-816	18	10	13	13	NUM
gra-816	18	11	13.0	13.0	NUM
gra-816	18	12	%	%	NOUN
gra-816	18	13	ii	ii	NUM
gra-816	18	14	count	count	NOUN
gra-816	18	15	%	%	NOUN
gra-816	18	16	9	9	NUM
gra-816	18	17	12.9	12.9	NUM
gra-816	18	18	%	%	NOUN
gra-816	18	19	13	13	NUM
gra-816	18	20	43.3	43.3	NUM
gra-816	18	21	%	%	NOUN
gra-816	18	22	22	22	NUM
gra-816	18	23	22.0	22.0	NUM
gra-816	18	24	%	%	NOUN
gra-816	18	25	iii	iii	NUM
gra-816	18	26	count	count	NOUN
gra-816	18	27	%	%	NOUN
gra-816	18	28	5	5	NUM
gra-816	18	29	7.1	7.1	NUM
gra-816	18	30	%	%	NOUN
gra-816	18	31	8	8	NUM
gra-816	18	32	26.7	26.7	NUM
gra-816	18	33	%	%	NOUN
gra-816	18	34	13	13	NUM
gra-816	18	35	13.0	13.0	NUM
gra-816	18	36	%	%	NOUN
gra-816	18	37	iv	iv	NUM
gra-816	18	38	count	count	NOUN
gra-816	18	39	%	%	NOUN
gra-816	18	40	4	4	NUM
gra-816	18	41	5.7	5.7	NUM
gra-816	18	42	%	%	NOUN
gra-816	18	43	5	5	NUM
gra-816	18	44	16.7	16.7	NUM
gra-816	18	45	%	%	NOUN
gra-816	18	46	9	9	NUM
gra-816	18	47	9.0	9.0	NUM
gra-816	18	48	%	%	NOUN
gra-816	18	49	n	n	CCONJ
gra-816	18	50	count	count	VERB
gra-816	18	51	%	%	NOUN
gra-816	18	52	41	41	NUM
gra-816	18	53	58.6	58.6	NUM
gra-816	18	54	%	%	NOUN
gra-816	18	55	2	2	NUM
gra-816	18	56	6.7	6.7	NUM
gra-816	18	57	%	%	NOUN
gra-816	18	58	43	43	NUM
gra-816	18	59	43.0	43.0	NUM
gra-816	18	60	%	%	NOUN
gra-816	18	61	total	total	ADJ
gra-816	18	62	count	count	NOUN
gra-816	18	63	70	70	NUM
gra-816	18	64	100.0	100.0	NUM
gra-816	18	65	%	%	NOUN
gra-816	18	66	30	30	NUM
gra-816	18	67	100.0	100.0	NUM
gra-816	18	68	%	%	NOUN
gra-816	19	1	100	100	NUM
gra-816	19	2	100.0	100.0	NUM
gra-816	19	3	%	%	NOUN
gra-816	19	4	lipid	lipid	NOUN
gra-816	19	5	pofile	pofile	NOUN
gra-816	19	6	count	count	NOUN
gra-816	19	7	%	%	NOUN
gra-816	19	8	ma	ma	PROPN
gra-816	19	9	total	total	NOUN
gra-816	19	10	a	a	DET
gra-816	19	11	p	p	X
gra-816	19	12	f	f	PROPN
gra-816	19	13	count	count	NOUN
gra-816	19	14	%	%	NOUN
gra-816	19	15	56	56	NUM
gra-816	19	16	80.0	80.0	NUM
gra-816	19	17	%	%	NOUN
gra-816	19	18	7	7	NUM
gra-816	19	19	23.3	23.3	NUM
gra-816	19	20	%	%	NOUN
gra-816	19	21	63	63	NUM
gra-816	19	22	63.0	63.0	NUM
gra-816	19	23	%	%	NOUN
gra-816	19	24	nf	nf	NOUN
gra-816	19	25	count	count	NOUN
gra-816	19	26	%	%	NOUN
gra-816	19	27	14	14	NUM
gra-816	19	28	20.0	20.0	NUM
gra-816	19	29	%	%	NOUN
gra-816	19	30	7	7	NUM
gra-816	19	31	76.7	76.7	NUM
gra-816	19	32	%	%	NOUN
gra-816	19	33	37	37	NUM
gra-816	19	34	37.0	37.0	NUM
gra-816	19	35	%	%	NOUN
gra-816	19	36	total	total	ADJ
gra-816	19	37	count	count	NOUN
gra-816	19	38	%	%	NOUN
gra-816	19	39	70	70	NUM
gra-816	19	40	100.0	100.0	NUM
gra-816	19	41	%	%	NOUN
gra-816	19	42	30	30	NUM
gra-816	19	43	100.0	100.0	NUM
gra-816	19	44	%	%	NOUN
gra-816	19	45	100	100	NUM
gra-816	19	46	100.0	100.0	NUM
gra-816	19	47	%	%	NOUN
gra-816	19	48	x	x	SYM
gra-816	19	49	37gjra	37gjra	NUM
gra-816	19	50	global	global	ADJ
gra-816	19	51	journal	journal	PROPN
gra-816	19	52	for	for	ADP
gra-816	19	53	research	research	NOUN
gra-816	19	54	analysis	analysis	NOUN
gra-816	19	55	organ	organ	NOUN
gra-816	19	56	damage	damage	NOUN
gra-816	19	57	and	and	CCONJ
gra-816	19	58	this	this	DET
gra-816	19	59	study	study	NOUN
gra-816	19	60	focused	focus	VERB
gra-816	19	61	on	on	ADP
gra-816	19	62	fundus	fundus	NOUN
gra-816	19	63	examination	examination	NOUN
gra-816	19	64	,	,	PUNCT
gra-816	19	65	correlating	correlate	VERB
gra-816	19	66	with	with	ADP
gra-816	19	67	the	the	DET
gra-816	19	68	respective	respective	ADJ
gra-816	19	69	department.patients	department.patient	NOUN
gra-816	19	70	were	be	AUX
gra-816	19	71	included	include	VERB
gra-816	19	72	based	base	VERB
gra-816	19	73	on	on	ADP
gra-816	19	74	the	the	DET
gra-816	19	75	inclusive	inclusive	ADJ
gra-816	19	76	and	and	CCONJ
gra-816	19	77	exclusion	exclusion	NOUN
gra-816	19	78	criteria	criterion	NOUN
gra-816	19	79	as	as	SCONJ
gra-816	19	80	described	describe	VERB
gra-816	19	81	above	above	ADV
gra-816	19	82	in	in	ADP
gra-816	19	83	present	present	ADJ
gra-816	19	84	study	study	NOUN
gra-816	19	85	,	,	PUNCT
gra-816	19	86	it	it	PRON
gra-816	19	87	was	be	AUX
gra-816	19	88	observed	observe	VERB
gra-816	19	89	that	that	SCONJ
gra-816	19	90	out	out	ADP
gra-816	19	91	of	of	ADP
gra-816	19	92	100	100	NUM
gra-816	19	93	cases	case	NOUN
gra-816	19	94	with	with	ADP
gra-816	19	95	hypertension	hypertension	NOUN
gra-816	19	96	,	,	PUNCT
gra-816	19	97	retinopathy	retinopathy	ADJ
gra-816	19	98	noted	note	VERB
gra-816	19	99	in	in	ADP
gra-816	19	100	57	57	NUM
gra-816	19	101	patients	patient	NOUN
gra-816	19	102	,	,	PUNCT
gra-816	19	103	and	and	CCONJ
gra-816	19	104	normal	normal	ADJ
gra-816	19	105	in	in	ADP
gra-816	19	106	43	43	NUM
gra-816	19	107	patients	patient	NOUN
gra-816	19	108	.13	.13	NUM
gra-816	19	109	patients	patient	NOUN
gra-816	19	110	had	have	VERB
gra-816	19	111	stage	stage	NOUN
gra-816	19	112	1	1	NUM
gra-816	19	113	retinopathy,22	retinopathy,22	NOUN
gra-816	19	114	with	with	ADP
gra-816	19	115	stage	stage	NOUN
gra-816	19	116	ii,13	ii,13	PROPN
gra-816	19	117	with	with	ADP
gra-816	19	118	stage	stage	NOUN
gra-816	19	119	iii,9	iii,9	NOUN
gra-816	19	120	with	with	ADP
gra-816	19	121	stage	stage	NOUN
gra-816	19	122	iv.13	iv.13	NOUN
gra-816	19	123	of	of	ADP
gra-816	19	124	22	22	NUM
gra-816	19	125	patients	patient	NOUN
gra-816	19	126	with	with	ADP
gra-816	19	127	stage	stage	NOUN
gra-816	19	128	ii	ii	PROPN
gra-816	19	129	had	have	VERB
gra-816	19	130	ma,5	ma,5	NOUN
gra-816	19	131	of	of	ADP
gra-816	19	132	9	9	NUM
gra-816	19	133	with	with	ADP
gra-816	19	134	stage	stage	NOUN
gra-816	19	135	iv	iv	NUM
gra-816	19	136	had	have	VERB
gra-816	19	137	ma,8	ma,8	NOUN
gra-816	19	138	of	of	ADP
gra-816	19	139	13	13	NUM
gra-816	19	140	with	with	ADP
gra-816	19	141	stage	stage	NOUN
gra-816	19	142	iii	iii	NUM
gra-816	19	143	had	have	VERB
gra-816	19	144	ma,2	ma,2	NOUN
gra-816	19	145	of	of	ADP
gra-816	19	146	43	43	NUM
gra-816	19	147	patients	patient	NOUN
gra-816	19	148	with	with	ADP
gra-816	19	149	normal	normal	ADJ
gra-816	19	150	fundus	fundus	NOUN
gra-816	19	151	had	have	VERB
gra-816	19	152	ma	ma	PROPN
gra-816	19	153	.p	.p	PROPN
gra-816	19	154	value	value	NOUN
gra-816	19	155	is	be	AUX
gra-816	19	156	<	<	X
gra-816	19	157	0.01	0.01	NUM
gra-816	19	158	which	which	PRON
gra-816	19	159	is	be	AUX
gra-816	19	160	highly	highly	ADV
gra-816	19	161	signicant	signicant	ADJ
gra-816	19	162	.	.	PUNCT
gra-816	20	1	hence	hence	ADV
gra-816	20	2	this	this	DET
gra-816	20	3	study	study	NOUN
gra-816	20	4	shows	show	VERB
gra-816	20	5	a	a	DET
gra-816	20	6	positive	positive	ADJ
gra-816	20	7	correlation	correlation	NOUN
gra-816	20	8	between	between	ADP
gra-816	20	9	the	the	DET
gra-816	20	10	microalbuminuria	microalbuminuria	NOUN
gra-816	20	11	and	and	CCONJ
gra-816	20	12	prevalence	prevalence	NOUN
gra-816	20	13	of	of	ADP
gra-816	20	14	retinopathy(p	retinopathy(p	NOUN
gra-816	20	15	value	value	NOUN
gra-816	20	16	<	<	X
gra-816	20	17	0.01).hypertensive	0.01).hypertensive	ADJ
gra-816	20	18	patients	patient	NOUN
gra-816	20	19	with	with	ADP
gra-816	20	20	ma	ma	PROPN
gra-816	20	21	were	be	AUX
gra-816	20	22	10	10	NUM
gra-816	20	23	times	time	NOUN
gra-816	20	24	more	more	ADV
gra-816	20	25	likely	likely	ADJ
gra-816	20	26	to	to	PART
gra-816	20	27	develop	develop	VERB
gra-816	20	28	retinopathy	retinopathy	ADJ
gra-816	20	29	than	than	ADP
gra-816	20	30	patients	patient	NOUN
gra-816	20	31	with	with	ADP
gra-816	20	32	normal	normal	ADJ
gra-816	20	33	uae	uae	PROPN
gra-816	20	34	.	.	PUNCT
gra-816	21	1	keith	keith	PROPN
gra-816	21	2	wegner	wegner	PROPN
gra-816	21	3	baker	baker	PROPN
gra-816	21	4	classication	classication	PROPN
gra-816	21	5	of	of	ADP
gra-816	21	6	retinopathy	retinopathy	ADJ
gra-816	21	7	severe	severe	ADJ
gra-816	21	8	retinopathy	retinopathy	NOUN
gra-816	21	9	can	can	AUX
gra-816	21	10	cause	cause	VERB
gra-816	21	11	visual	visual	ADJ
gra-816	21	12	eld	eld	NOUN
gra-816	21	13	defects	defect	NOUN
gra-816	21	14	and	and	CCONJ
gra-816	21	15	blindness	blindness	NOUN
gra-816	21	16	conclusions	conclusion	NOUN
gra-816	21	17	our	our	PRON
gra-816	21	18	study	study	NOUN
gra-816	21	19	demonstrated	demonstrate	VERB
gra-816	21	20	the	the	DET
gra-816	21	21	presence	presence	NOUN
gra-816	21	22	of	of	ADP
gra-816	21	23	ma	ma	PROPN
gra-816	21	24	(	(	PUNCT
gra-816	21	25	microalbu	microalbu	PROPN
gra-816	21	26	minuria	minuria	PROPN
gra-816	21	27	)	)	PUNCT
gra-816	21	28	in	in	ADP
gra-816	21	29	a	a	DET
gra-816	21	30	signicant	signicant	ADJ
gra-816	21	31	number	number	NOUN
gra-816	21	32	of	of	ADP
gra-816	21	33	newly	newly	ADV
gra-816	21	34	detected	detect	VERB
gra-816	21	35	and	and	CCONJ
gra-816	21	36	untreated	untreated	ADJ
gra-816	21	37	patients	patient	NOUN
gra-816	21	38	of	of	ADP
gra-816	21	39	essential	essential	ADJ
gra-816	21	40	hypertension	hypertension	NOUN
gra-816	21	41	.	.	PUNCT
gra-816	22	1	furthermore	furthermore	ADV
gra-816	22	2	,	,	PUNCT
gra-816	22	3	ma	ma	PROPN
gra-816	22	4	had	have	VERB
gra-816	22	5	a	a	DET
gra-816	22	6	statistically	statistically	ADV
gra-816	22	7	signicant	signicant	ADJ
gra-816	22	8	relationship	relationship	NOUN
gra-816	22	9	with	with	ADP
gra-816	22	10	retinopathy	retinopathy	NOUN
gra-816	22	11	.	.	PUNCT
gra-816	23	1	these	these	DET
gra-816	23	2	ndings	nding	NOUN
gra-816	23	3	imply	imply	VERB
gra-816	23	4	an	an	DET
gra-816	23	5	underlying	underlie	VERB
gra-816	23	6	vascular	vascular	ADJ
gra-816	23	7	relationship	relationship	NOUN
gra-816	23	8	between	between	ADP
gra-816	23	9	ma	ma	PROPN
gra-816	23	10	and	and	CCONJ
gra-816	23	11	retinopathy	retinopathy	ADJ
gra-816	23	12	.	.	PUNCT
gra-816	24	1	therefore	therefore	ADV
gra-816	24	2	,	,	PUNCT
gra-816	24	3	screening	screen	VERB
gra-816	24	4	of	of	ADP
gra-816	24	5	all	all	DET
gra-816	24	6	recently	recently	ADV
gra-816	24	7	diagnosed	diagnose	VERB
gra-816	24	8	patients	patient	NOUN
gra-816	24	9	of	of	ADP
gra-816	24	10	essential	essential	ADJ
gra-816	24	11	hypertension	hypertension	NOUN
gra-816	24	12	for	for	ADP
gra-816	24	13	ma	ma	PROPN
gra-816	24	14	may	may	AUX
gra-816	24	15	be	be	AUX
gra-816	24	16	a	a	DET
gra-816	24	17	reasonable	reasonable	ADJ
gra-816	24	18	strategy	strategy	NOUN
gra-816	24	19	to	to	PART
gra-816	24	20	predict	predict	VERB
gra-816	24	21	the	the	DET
gra-816	24	22	presence	presence	NOUN
gra-816	24	23	of	of	ADP
gra-816	24	24	ongoing	ongoing	ADJ
gra-816	24	25	vascular	vascular	ADJ
gra-816	24	26	damage	damage	NOUN
gra-816	24	27	,	,	PUNCT
gra-816	24	28	and	and	CCONJ
gra-816	24	29	retinal	retinal	ADJ
gra-816	24	30	damage	damage	NOUN
gra-816	24	31	.	.	PUNCT
gra-816	25	1	financial	financial	ADJ
gra-816	25	2	support	support	NOUN
gra-816	25	3	:	:	PUNCT
gra-816	25	4	nil	nil	ADJ
gra-816	25	5	conicts	conict	NOUN
gra-816	25	6	of	of	ADP
gra-816	25	7	intrest	intrest	NOUN
gra-816	25	8	:	:	PUNCT
gra-816	25	9	there	there	PRON
gra-816	25	10	are	be	VERB
gra-816	25	11	no	no	DET
gra-816	25	12	conicts	conict	NOUN
gra-816	25	13	of	of	ADP
gra-816	25	14	intrest	intrest	PROPN
gra-816	25	15	references	reference	NOUN
gra-816	25	16	1	1	NUM
gra-816	25	17	.	.	PUNCT
gra-816	25	18	systemic	systemic	ADJ
gra-816	25	19	hypertension	hypertension	NOUN
gra-816	25	20	:	:	PUNCT
gra-816	25	21	mechanism	mechanism	NOUN
gra-816	25	22	and	and	CCONJ
gra-816	25	23	diagnosis	diagnosis	NOUN
gra-816	25	24	in	in	ADP
gra-816	25	25	braunwalds	braunwald	NOUN
gra-816	25	26	heart	heart	NOUN
gra-816	25	27	disease.a	disease.a	NOUN
gra-816	25	28	text	text	NOUN
gra-816	25	29	book	book	NOUN
gra-816	25	30	of	of	ADP
gra-816	25	31	cardiovascular	cardiovascular	ADJ
gra-816	25	32	medicine	medicine	NOUN
gra-816	25	33	2	2	NUM
gra-816	25	34	.	.	PUNCT
gra-816	26	1	brantsma	brantsma	PROPN
gra-816	26	2	ah	ah	INTJ
gra-816	26	3	,	,	PUNCT
gra-816	26	4	bakker	bakker	PROPN
gra-816	26	5	sj.urinary	sj.urinary	PROPN
gra-816	26	6	albumin	albumin	PROPN
gra-816	26	7	excretion	excretion	NOUN
gra-816	26	8	as	as	ADP
gra-816	26	9	a	a	DET
gra-816	26	10	predictor	predictor	NOUN
gra-816	26	11	of	of	ADP
gra-816	26	12	development	development	NOUN
gra-816	26	13	of	of	ADP
gra-816	26	14	hypertension	hypertension	NOUN
gra-816	26	15	in	in	ADP
gra-816	26	16	the	the	DET
gra-816	26	17	general	general	ADJ
gra-816	26	18	population	population	NOUN
gra-816	26	19	3	3	X
gra-816	26	20	.	.	PUNCT
gra-816	26	21	pontremoli	pontremoli	PROPN
gra-816	26	22	r	r	PROPN
gra-816	26	23	,	,	PUNCT
gra-816	26	24	leoncini	leoncini	VERB
gra-816	26	25	g	g	NOUN
gra-816	26	26	,	,	PUNCT
gra-816	26	27	ravera	ravera	NOUN
gra-816	26	28	m	m	PROPN
gra-816	26	29	,	,	PUNCT
gra-816	26	30	ratto	ratto	NOUN
gra-816	26	31	e	e	NOUN
gra-816	26	32	,	,	PUNCT
gra-816	26	33	et	et	NOUN
gra-816	26	34	al.microalbuminuria	al.microalbuminuria	NOUN
gra-816	26	35	,	,	PUNCT
gra-816	26	36	cardiovascular	cardiovascular	ADJ
gra-816	26	37	,	,	PUNCT
gra-816	26	38	and	and	CCONJ
gra-816	26	39	renal	renal	ADJ
gra-816	26	40	risk	risk	NOUN
gra-816	26	41	in	in	ADP
gra-816	26	42	primary	primary	ADJ
gra-816	26	43	hypertension	hypertension	NOUN
gra-816	26	44	4	4	NUM
gra-816	26	45	.	.	PUNCT
gra-816	26	46	cardio	cardio	ADJ
gra-816	26	47	vascular	vascular	NOUN
gra-816	26	48	diseases	disease	NOUN
gra-816	26	49	harrisons	harrison	NOUN
gra-816	26	50	textbook	textbook	NOUN
gra-816	26	51	of	of	ADP
gra-816	26	52	medicine	medicine	NOUN
gra-816	26	53	5	5	NUM
gra-816	26	54	.	.	PUNCT
gra-816	26	55	bigazzi	bigazzi	NOUN
gra-816	26	56	r	r	PROPN
gra-816	26	57	,	,	PUNCT
gra-816	26	58	bianchi	bianchi	NOUN
gra-816	26	59	s	s	PART
gra-816	26	60	,	,	PUNCT
gra-816	26	61	nenci	nenci	NOUN
gra-816	26	62	r.increased	r.increase	VERB
gra-816	26	63	thickness	thickness	NOUN
gra-816	26	64	of	of	ADP
gra-816	26	65	the	the	DET
gra-816	26	66	carotid	carotid	NOUN
gra-816	26	67	artery	artery	NOUN
gra-816	26	68	in	in	ADP
gra-816	26	69	patients	patient	NOUN
gra-816	26	70	with	with	ADP
gra-816	26	71	essential	essential	ADJ
gra-816	26	72	hypertension	hypertension	NOUN
gra-816	26	73	and	and	CCONJ
gra-816	26	74	micro	micro	ADJ
gra-816	26	75	albuminuria	albuminuria	PROPN
gra-816	26	76	.	.	PUNCT
gra-816	27	1	volume-8	volume-8	NUM
gra-816	27	2	,	,	PUNCT
gra-816	27	3	issue-11	issue-11	PROPN
gra-816	27	4	,	,	PUNCT
gra-816	27	5	november-2019	november-2019	ADJ
gra-816	27	6	•	•	NOUN
gra-816	27	7	print	print	NOUN
gra-816	27	8	issn	issn	PROPN
gra-816	27	9	no	no	NOUN
gra-816	27	10	.	.	PROPN
gra-816	28	1	2277	2277	NUM
gra-816	28	2	8160	8160	NUM
gra-816	28	3	•	•	NOUN
gra-816	28	4	doi	doi	NOUN
gra-816	28	5	:	:	PUNCT
gra-816	28	6	10.36106	10.36106	NUM
gra-816	28	7	/	/	SYM
gra-816	28	8	gjra	gjra	NOUN
gra-816	28	9	38	38	NUM
gra-816	28	10	x	x	SYM
gra-816	28	11	gjra	gjra	ADJ
gra-816	28	12	global	global	ADJ
gra-816	28	13	journal	journal	PROPN
gra-816	28	14	for	for	ADP
gra-816	28	15	research	research	NOUN
gra-816	28	16	analysis	analysis	NOUN